163 related articles for article (PubMed ID: 11006244)
1. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
[TBL] [Abstract][Full Text] [Related]
2. The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.
Jha P; Sohn JH; Xu Q; Nishihori H; Wang Y; Nishihori S; Manickam B; Kaplan HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1030-8. PubMed ID: 16505038
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of complement regulation is key to the pathogenesis of active Heymann nephritis.
Schiller B; He C; Salant DJ; Lim A; Alexander JJ; Quigg RJ
J Exp Med; 1998 Oct; 188(7):1353-8. PubMed ID: 9763614
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.
Quigg RJ; He C; Lim A; Berthiaume D; Alexander JJ; Kraus D; Holers VM
J Exp Med; 1998 Oct; 188(7):1321-31. PubMed ID: 9763611
[TBL] [Abstract][Full Text] [Related]
5. Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system.
Karbian N; Eshed-Eisenbach Y; Zeibak M; Tabib A; Sukhanov N; Vainshtein A; Morgan BP; Fellig Y; Peles E; Mevorach D
J Neuroinflammation; 2023 Oct; 20(1):245. PubMed ID: 37875972
[TBL] [Abstract][Full Text] [Related]
6. Expression of 17-1A antigen and complement resistance factors CD55 and CD59 on liver metastasis in colorectal cancer.
Hosch SB; Scheunemann P; Lüth M; Inndorf S; Stoecklein NH; Erbersdobler A; Rehders A; Gundlach M; Knoefel WT; Izbicki JR
J Gastrointest Surg; 2001; 5(6):673-9. PubMed ID: 12086907
[TBL] [Abstract][Full Text] [Related]
7. Membrane cofactor protein (MCP; CD46) expression in transgenic mice.
Kemper C; Leung M; Stephensen CB; Pinkert CA; Liszewski MK; Cattaneo R; Atkinson JP
Clin Exp Immunol; 2001 May; 124(2):180-9. PubMed ID: 11422193
[TBL] [Abstract][Full Text] [Related]
8. Targeting of functional antibody-CD59 fusion proteins to a cell surface.
Zhang HF; Yu J; Bajwa E; Morrison SL; Tomlinson S
J Clin Invest; 1999 Jan; 103(1):55-61. PubMed ID: 9884334
[TBL] [Abstract][Full Text] [Related]
9. Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients.
Ge X; Yu Z; Guo X; Li L; Ye L; Ye M; Yuan J; Zhu C; Hu W; Hou Y
Pathol Res Pract; 2023 Jul; 247():154519. PubMed ID: 37244049
[TBL] [Abstract][Full Text] [Related]
10. Exploring the involvement of the alternative complement pathway in non-infectious uveitis pathogenesis.
Kulshrestha P; Goel P; Murthy S; Tyagi M; Basu S; Gogri P; Kaur I
Front Immunol; 2023; 14():1222998. PubMed ID: 38187376
[TBL] [Abstract][Full Text] [Related]
11. Cytolytic complement activity in otitis media with effusion.
Närkiö-Mäkelä M; Meri S
Clin Exp Immunol; 2001 Jun; 124(3):369-76. PubMed ID: 11472396
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies.
Lin F; Fukuoka Y; Spicer A; Ohta R; Okada N; Harris CL; Emancipator SN; Medof ME
Immunology; 2001 Oct; 104(2):215-25. PubMed ID: 11683962
[TBL] [Abstract][Full Text] [Related]
13. Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients.
Watson NF; Durrant LG; Madjd Z; Ellis IO; Scholefield JH; Spendlove I
Cancer Immunol Immunother; 2006 Aug; 55(8):973-80. PubMed ID: 16151805
[TBL] [Abstract][Full Text] [Related]
14. Mapping the active site of CD59.
Yu J; Abagyan R; Dong S; Gilbert A; Nussenzweig V; Tomlinson S
J Exp Med; 1997 Feb; 185(4):745-53. PubMed ID: 9034152
[TBL] [Abstract][Full Text] [Related]
15. Anti-Thy-1 Antibody-mediated Complement-dependent Cytotoxicity is Regulated by the Distribution of Antigen, Antibody and Membrane Complement Regulatory Proteins in Rats.
Kato C; Kato A; Adachi K; Fujii E; Isobe K; Matsushita T; Watanabe T; Suzuki M
J Toxicol Pathol; 2013 Mar; 26(1):41-9. PubMed ID: 23723567
[TBL] [Abstract][Full Text] [Related]
16. Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model.
Kamegai N; Kim H; Suzuki Y; Fukui S; Kojima H; Maruyama S; Morgan BP; Zelek WM; Mizuno M
Clin Exp Immunol; 2023 Dec; 214(2):209-218. PubMed ID: 37549240
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack.
Okroj M; Corrales L; Stokowska A; Pio R; Blom AM
Cancer Immunol Immunother; 2009 Nov; 58(11):1771-80. PubMed ID: 19259664
[TBL] [Abstract][Full Text] [Related]
18. Structures of the rat complement regulator CrrY.
Roversi P; Johnson S; Caesar JJ; McLean F; Leath KJ; Tsiftsoglou SA; Morgan BP; Harris CL; Sim RB; Lea SM
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jul; 67(Pt 7):739-43. PubMed ID: 21795784
[TBL] [Abstract][Full Text] [Related]
19. Complement Inhibition Targeted to Injury Specific Neoepitopes Attenuates Atherogenesis in Mice.
Dai S; Liu F; Ren M; Qin Z; Rout N; Yang XF; Wang H; Tomlinson S; Qin X
Front Cardiovasc Med; 2021; 8():731315. PubMed ID: 34651027
[No Abstract] [Full Text] [Related]
20. Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation.
Michielsen LA; Budding K; Drop D; van de Graaf EA; Kardol-Hoefnagel T; Verhaar MC; van Zuilen AD; Otten HG
Front Immunol; 2017; 8():2008. PubMed ID: 29403484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
